Clinical Trial Update: Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a novel combination therapy in relapsed or refractory aggressive B-cell lymphoma (diffuse large B-cell lymphoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING